Literature DB >> 23182804

Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France.

Serena Lattante1, Isabelle Le Ber, Agnès Camuzat, Alexis Brice, Edor Kabashi.   

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are 2 adult onset neurological disorders with overlapping symptoms and clinical characteristics. It is well established that they share a common pathologic and genetic background. Recently, mutations in profilin 1 gene (PFN1) have been identified in patients with familial ALS, suggesting a role for this gene in the pathogenesis of the disease. Based on this, we hypothesized that mutations in PFN1 might also contribute to FTLD disease. We studied a French cohort of 165 ALS/FTLD patients, without finding any variant. We conclude that mutations in PFN1 are not a common cause for ALS/FTLD in France.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182804     DOI: 10.1016/j.neurobiolaging.2012.10.026

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

Review 1.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics.

Authors:  Matthew D Figley; Gregor Bieri; Regina-Maria Kolaitis; J Paul Taylor; Aaron D Gitler
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

Review 4.  Profilin1 biology and its mutation, actin(g) in disease.

Authors:  Duah Alkam; Ezra Z Feldman; Awantika Singh; Mahmoud Kiaei
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

5.  Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.

Authors:  Serena Lattante; Stéphanie Millecamps; Giovanni Stevanin; Sophie Rivaud-Péchoux; Carine Moigneu; Agnès Camuzat; Sandra Da Barroca; Emeline Mundwiller; Philippe Couarch; François Salachas; Didier Hannequin; Vincent Meininger; Florence Pasquier; Danielle Seilhean; Philippe Couratier; Véronique Danel-Brunaud; Anne-Marie Bonnet; Christine Tranchant; Eric LeGuern; Alexis Brice; Isabelle Le Ber; Edor Kabashi
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

Review 6.  State of play in amyotrophic lateral sclerosis genetics.

Authors:  Alan E Renton; Adriano Chiò; Bryan J Traynor
Journal:  Nat Neurosci       Date:  2013-12-26       Impact factor: 24.884

7.  PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis.

Authors:  Enrique Syriani; Candi Salvans; Maria Salvadó; Miguel Morales; Laura Lorenzo; Sonia Cazorla; Josep Gamez
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

8.  Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Marka van Blitterswijk; Matthew C Baker; Kevin F Bieniek; David S Knopman; Keith A Josephs; Bradley Boeve; Richard Caselli; Zbigniew K Wszolek; Ronald Petersen; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Rosa Rademakers
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05-02       Impact factor: 4.092

9.  Profilin1 E117G is a moderate risk factor for amyotrophic lateral sclerosis.

Authors:  Pietro Fratta; James Charnock; Toby Collins; Anny Devoy; Robin Howard; Andrea Malaspina; Richard Orrell; Katie Sidle; Jan Clarke; Maryam Shoai; Ching-Hua Lu; John Hardy; Vincent Plagnol; Elizabeth M C Fisher
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-12-05       Impact factor: 10.154

10.  Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.

Authors:  Bradley N Smith; Caroline Vance; Emma L Scotter; Claire Troakes; Chun Hao Wong; Simon Topp; Satomi Maekawa; Andrew King; Jacqueline C Mitchell; Karan Lund; Ammar Al-Chalabi; Nicola Ticozzi; Vincenzo Silani; Peter Sapp; Robert H Brown; John E Landers; Safa Al-Sarraj; Christopher E Shaw
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.